SlideShare uma empresa Scribd logo
1 de 57
Graphs to fight
diabetes
Dr. Alexander Jarasch
Head of Data and Knowledge Management
The German Center for Diabetes Research
(DZD)
Evolutionary advantage becomes
disadvantage
energy storage
essential for survival
upon lack of food
energy storage
essential for survival
upon food abundance
What is diabetes mellitus?
• metabolic disease
• insulin production is reduced in pancreas or
body poorly responds on insulin
(insulin=hormone, the body needs to get glucose out of the blood
stream into the cells)
• consequences:
• less absorbtion of sugar
• sugar will not be stored in liver and muscle cells
• persistently high levels of sugar in blood (hyperglycemia)
• tremendous complications
• currently, not curable (only treatable)
diabetes
T1D
diabetes
Gestational
diabetes
special
types
T2D
diabetes
Diabetes TYPE 1 (T1D)
• appr. 5-10 % of diabetes patients have T1D
• often starts in childhood
• autoimmune reaction
• independent from life style
• patients need external insulin source
throughout their life
• appr. 20 genes involved
• currently, T1D is not curable
Diabetes TYPE 2 (T2D)
• appr. 90-95 % of diabetes patients have T2D
(mostly after age 40)
• insulin resistance, pancreas is not able to
produce enough insulin
• symptoms develop slowly
• >150 genes are identified that increase risk
• “the cocktail of evil“: predisposition +
overweight + physical inactivity
Some numbers (worldwide)
1 in 11 adults has diabetes (425 million)
Since 1980 quadrupled
12% of global health expenditure is spent on
diabetes ($727 billion)
Over 1 million children
and adolescents have
type 1 diabetes
Two-thirds of people with diabetes are of
working age (327 million)
2017
Three quarters of people with diabetes
live in low and middle income countries
2017
1 in 2 adults with diabetes is
undiagnosed (212 million)
International Diabetes Federation (IDF)
Some numbers (USA and Germany)
30 million have diabetes (9.4 % of adults )1
+1‘500‘000 p.a.
84 mio. prediabetes2
16 billion € costs p.a.1
7 million have diabetes (7.4 % of adults)1
+500‘000 p.a.
~ 7 mio. prediabetes and undiagnozed
$327 billion USD costs p.a.1
($237 bn. medical costs,
$90 bn. reduced productivity)2
1 www.statistica.com 2 American Diabetes Association
Overweight/obesity in the US (1985-
2009) obese adults in the US (BMI* >= 30)
*BMI=30: 5”11 = 220,46 lbs (180cm = 100 kg)
Complications develop after many years
kidney
Diabetic nephropathy
40 % of kidney failure/dialysis
feet
70 % of all foot
amputations
eyes
Diabetic retinopathy
30 % of loss of sight
brain
2-4 fold increased risk
for stroke
acute cardiac death
Main reason of death of diabetic patients
(33 % of all heart attacks)
nerves
Diabetic Neuropathy
Amputations of
extremeties
Complex emergence / complex disease
live style
gene epigenetics
metabolism
cellular
processes
environment
Inherited lifestyle
genetically
identical
epigenetically different
Epigenetics – beyond generation
weight[g]
age [weeks]
daughters of
obese mice
having diabtes
daughters of
healthy mice
Huypens and Beckers, Nat Genet. 2016
The German Center for Diabetes Research
funded by the Federal Ministry for
Education and Research and the states
5 Partners, 5 associated partners – 400 researchers (basic research and university hospitals)
DZD bundles competencies so that those affected benefit more quickly from research results.
academic, non-profit
The German Center for Diabetes Research
hospitals
prevention
nutrition / diet
beta cells
genetics
therapy
clinial studies
cohorts
basic researchhealthcare
diabetes
treatment
diabetes
prevention
prevention of
complications
Goal:
better diabetes prevention and therapy
personalized prevention and therapy
identify and cluster diabetes subtypes
individualized treatment of subtypes
How do we fight diabetes with graphs?
The challenge
Easy question -> Complex query
Find information within our organisation
Originally different research areas
Hospitals
Basic
Research
Data
Analysis
We all “serve“ the same “customer“
Hospitals
Basic
Research
Data
Analysis
But we all see the “customer“ a little
differently
“Patient“
“Gene“
“Study“
“Metabolite“
“drug“
“statistics“
64kg, 178cm, male
C6H12O6
Metformin
T2D
AAGCTTCACATGG
cell
insulin resistance
inactive
mice
prediabetic pig
microscope
image
complications
Look at our “customer“ in a new way
“Patient“
“Gene“
“Study“
“Metabolite“
“drug“
“statistics“
64kg, 178cm, male
C6H12O6
Metformin
T2D
AAGCTTCACATGG
cell
insulin resistance
inactive
mice
prediabetic pig
microscope
image
complications
Look at our “customer“ from many
perspectives simultaneously – connect data
Hospitals
Basic
Research
Data
Analysis
data
Connect data – one option
Hospitals
Basic
Research
Data
Analysis
“Patient“
64kg, 178cm, male
“drug“
Metformin
“Study“
T2D
insulin resistance
“Gene“
AAGCTTCACATGG
“Metabolite“
C6H12O6
cell
inactive
mice
prediabetic pig
“statistics“
microscope
image
complications
Connect data – better option
“Patient“
64kg, 178cm, male
“drug“
Metformin
“Study“
T2D
“statistics“
“Gene“
AAGCTTCACATGG
“Metabolite“
C6H12O6
insulin resistance
cell
inactive
mice
prediabetic pig
microscope
image
complications
DZDConnect – a Neo4j graph database
Graph that can help answering
bio-medical questions
across locations
across disciplines
across species
extendable
scalable
visualizable
Homogenous and heterogenous data
(First) connect data a meta level
RAW
DATA
RAW
DATA
RAW
DATA
RAW
DATA
RAW
DATA
Classify types of data
Classify types of data
clin.
study
clin.
study
clin.
study
statis
tics
statis
tics
RNA
DNA
RNA
DNA
images
chem
istry
patient
patient
patient
bio
sample
bio
sample bio
sample
wet
lab
chem
istry
drug
Connect types of data
statis
tics
statis
tics
RNA
DNA
images
chem
istry
patient
wet
lab
chem
istry
drug
patient
patient
bio
sample
bio
sample bio
sample
clin.
study
clin.
study
clin.
study
RNA
DNA
Build graph model
clin.
study
statis
tics
RNA
DNA
images
bio
sample
wet
lab
chem
istry
drug
patient
Why graph?
• in „biology“ everything is connected anyway
• data is connected
• human readable – easy-to-understand for non-computer
scientists
• easy to query: queries are similar to human-like questions
• scalable
• easy-adoptable and extendable
• visualization
Meta data
name: IL-6
unit: mg/ml
sample: blood
organism: pig
amount: 50ml
aliquots: 362
location: Freezer68
name: pancreas dissection
format: TIFF
dimension: 3840x2160
amount: 125
staining: no staining
microscope: Zeiss Light sheet Z1
location: Dresden
title: „about diabetes and Alzheimer‘s“
PMID: 1255864
doi: http://doi.102r3d
year: 2016
journal: Diabetes
Extend graph
Literature
protein
database
other
diseases
Electronic
Laboratory
Notebook
lipid metabolism
Diabetes is a metabolic
disease
Extending our graph
RNA-seq
proteomicsAssociations
~800 mio. nodes
~800 mio. relationships
Dr. Martin Preusse
Dr. Nikola Müller
Extending our graph
Dr. Jan Krumsiek, Assistant Professor, Weill Cornell Medicine, NYC
metabolic pathway data
from 15-20 very rich data sources
~900’000 nodes
~1.7 mio. relationships
phenotype associations studies
Summary
“Patient“
64kg, 178cm, male
“drug“
Metformin
“Study“
T2D
“statistics“
“Gene“
AAGCTTCACATGG
“Metabolite“
C6H12O6
insulin resistance
cell
inactive
mice
prediabetic pig
microscope
image
complications
Examples
How many biosamples were aquired in visit
17 of ‘PLIS‘ and which parameters were
measured?Goals:
1. Connect data from our clinical studies and biobanks
2. Researches can easily browse through measured parameters and available biosamples
3. Meta data of parameters helps to assess which samples are comparable
name: HMGU
name: AJ
position: data mgmt
name: PLIS
multi-center: true
recruiting: closed
analysis: on-going
no. of patients: 1105
visit: 17
name: blood
type: OGTT
number of samples: 3436
organism: Human
name: laboratory
Study
Study
Person
Visit
Study
Person
Visit
BioSample
Experiment
Parameter
Can human T2D genes be studied in
the pre-diabetic pig model?
Goals:
1. Connect data from different species (i.e. mice, pig, human)
2. Connect multiomics data
3. Researches can easily find information between human and comparable data from animal models
genomics
transcriptomics
metabolomics
proteomics
Human GWAS cataloge (Diabetes)
103 genes
97 genes
96 genes
16 enzymes
63 compounds
31 compounds
7 compounds
16 metabolites
Targeted metabolomics
analysis in prediabetic pig
ENSEMBL
Gennamen (human)
KEGG Gen IDs
KEGG Enzyme
KEGG compounds
Biocrates IDs
7/16 metabolites
Xxaa C11:0
Xxaa C11:1
Xxaa C11:2
Xxaa C11:3
Xxaa C11:4
Xxaa C11:5
Xxaa C11:6
genomics
transcriptomics
proteomics
metabolomics
pathway analysis
Outlook
Automatically learn from large literature texts
Natural language processing (NLP) example
Identification of genetic elements in metabolism by high-throughput mouse
phenotyping.
Metabolic diseases are a worldwide problem but the underlying
genetic factors and their relevance to metabolic disease remain
incompletely understood. Genome-wide research is needed to
characterize so-far unannotated mammalian metabolic genes.
Here, we generate and analyze metabolic phenotypic data
of 2016 knockout mouse strains under the aegis of the
International Mouse Phenotyping Consortium (IMPC) and find 974
gene knockouts with strong metabolic phenotypes. 429 of those
had no previous link to metabolism and 51 genes remain functionally completely
unannotated. We compared human orthologues of these uncharacterized genes in
five GWAS consortia and indeed 23 candidate genes, like ABC1, XYZ2, are associated
with metabolic disease. We further identify common regulatory elements in promoters
of candidate genes. As each regulatory element is composed of several transcription
factor binding sites, our data reveal an extensive metabolic phenotype-associated
network of co-regulated genes.
Our systematic mouse phenotype analysis thus paves the way for full functional
annotation of the genome. Metabolic disorders, including obesity and type 2 diabetes
mellitus, are major challenges for public health.
Rozman and Hrabe de Angelis, Nat Commun. 2018 NLP method by GraphAware
Alzheimer‘s
cancer
cardio
vascular
diseases
diabetes
Lung
diseases
infectious
diseases
Find connections...
Machine learning for personalized prevention and
therapy
identify and cluster diabetes subtypes
individualized treatment of subtypes
Expert
Knowledge
validation of personalized treatment
Graph
Technology
DDPC – Digital Diabetes Prevention Center
• pattern recognition in huge amounts of data
• (un)supervised ML methods to identify subtypes of diabetes
• developing/validating individulized prevention/therapy
transparency to people benefit for people benefit for society
Next level in diabetes prevention and treatment
Hospitals
Basic
Research
Data
Analysis
Acknowledgements
The scientists of the DZD at: Funding by:
Thank you

Mais conteúdo relacionado

Mais procurados

Bill Faloon's presentation for Age Reversal webinar on Jan 23rd 2021
Bill Faloon's presentation for Age Reversal webinar on Jan 23rd 2021Bill Faloon's presentation for Age Reversal webinar on Jan 23rd 2021
Bill Faloon's presentation for Age Reversal webinar on Jan 23rd 2021maximuspeto
 
Koehne ebmt-2017-wt1-mm
Koehne ebmt-2017-wt1-mmKoehne ebmt-2017-wt1-mm
Koehne ebmt-2017-wt1-mmSellasCorp
 
John Ryals- Impacto de las ciencias ómicas en la medicina, nutrición y biotec...
John Ryals- Impacto de las ciencias ómicas en la medicina, nutrición y biotec...John Ryals- Impacto de las ciencias ómicas en la medicina, nutrición y biotec...
John Ryals- Impacto de las ciencias ómicas en la medicina, nutrición y biotec...Fundación Ramón Areces
 
Bill Faloon Age Reversal Update at DaVinci 50 Masters Conference 2021
Bill Faloon Age Reversal Update at DaVinci 50 Masters Conference 2021Bill Faloon Age Reversal Update at DaVinci 50 Masters Conference 2021
Bill Faloon Age Reversal Update at DaVinci 50 Masters Conference 2021maximuspeto
 
Bill Faloon's Keynote Speech from RAADfest 2021
Bill Faloon's Keynote Speech from RAADfest 2021Bill Faloon's Keynote Speech from RAADfest 2021
Bill Faloon's Keynote Speech from RAADfest 2021maximuspeto
 
Bill Faloon gives update about human age-reversal clinical studies
Bill Faloon gives update about human age-reversal clinical studiesBill Faloon gives update about human age-reversal clinical studies
Bill Faloon gives update about human age-reversal clinical studiesmaximuspeto
 
Effect of interlukin 36γ and tumor necrosis factorα on patients with polycyst...
Effect of interlukin 36γ and tumor necrosis factorα on patients with polycyst...Effect of interlukin 36γ and tumor necrosis factorα on patients with polycyst...
Effect of interlukin 36γ and tumor necrosis factorα on patients with polycyst...Alexander Decker
 
Targeting Biological Aging: A New Paradigm for 21st Century Medicine
Targeting Biological Aging: A New Paradigm for 21st Century MedicineTargeting Biological Aging: A New Paradigm for 21st Century Medicine
Targeting Biological Aging: A New Paradigm for 21st Century MedicineInsideScientific
 
Clinical Trials Update by Bill Faloon at RAADfest 2021
Clinical Trials Update by Bill Faloon at RAADfest 2021Clinical Trials Update by Bill Faloon at RAADfest 2021
Clinical Trials Update by Bill Faloon at RAADfest 2021maximuspeto
 
Unified Theory of Stem Cell Rejuvenation
Unified Theory of Stem Cell RejuvenationUnified Theory of Stem Cell Rejuvenation
Unified Theory of Stem Cell Rejuvenationmaximuspeto
 
April 25 webinar Bill Faloon presentation slides
April 25 webinar Bill Faloon presentation slides April 25 webinar Bill Faloon presentation slides
April 25 webinar Bill Faloon presentation slides maximuspeto
 
Pinilla ibarz-j.-et-al.-2006-leukemia
Pinilla ibarz-j.-et-al.-2006-leukemiaPinilla ibarz-j.-et-al.-2006-leukemia
Pinilla ibarz-j.-et-al.-2006-leukemiaSellasCorp
 
Bill Faloon at RAADfest 2020
Bill Faloon at RAADfest 2020Bill Faloon at RAADfest 2020
Bill Faloon at RAADfest 2020maximuspeto
 
Evaluation Of Type 1 Gaucher Disease Patients Treated Ith Imiglucerase
Evaluation Of Type 1 Gaucher Disease Patients Treated Ith ImigluceraseEvaluation Of Type 1 Gaucher Disease Patients Treated Ith Imiglucerase
Evaluation Of Type 1 Gaucher Disease Patients Treated Ith ImigluceraseMihaiela Fazacas
 
Advances in gaucher disease priya kishnani modified
Advances in gaucher disease  priya kishnani modifiedAdvances in gaucher disease  priya kishnani modified
Advances in gaucher disease priya kishnani modifiedSanjeev Kumar
 
Maslak p.g.-et-al.-asco-2016-phase-2-acute-myeloid-leukemia-oral-presentation
Maslak p.g.-et-al.-asco-2016-phase-2-acute-myeloid-leukemia-oral-presentationMaslak p.g.-et-al.-asco-2016-phase-2-acute-myeloid-leukemia-oral-presentation
Maslak p.g.-et-al.-asco-2016-phase-2-acute-myeloid-leukemia-oral-presentationSellasCorp
 
Bill Faloon's Keynote Speech from RAADfest 2021
Bill Faloon's Keynote Speech from RAADfest 2021Bill Faloon's Keynote Speech from RAADfest 2021
Bill Faloon's Keynote Speech from RAADfest 2021maximuspeto
 
IgG4 related disease Dr Suresh Gorka
IgG4  related disease Dr Suresh GorkaIgG4  related disease Dr Suresh Gorka
IgG4 related disease Dr Suresh GorkaSuresh Gorka
 

Mais procurados (20)

IgG4-related disease
IgG4-related diseaseIgG4-related disease
IgG4-related disease
 
Bill Faloon's presentation for Age Reversal webinar on Jan 23rd 2021
Bill Faloon's presentation for Age Reversal webinar on Jan 23rd 2021Bill Faloon's presentation for Age Reversal webinar on Jan 23rd 2021
Bill Faloon's presentation for Age Reversal webinar on Jan 23rd 2021
 
Koehne ebmt-2017-wt1-mm
Koehne ebmt-2017-wt1-mmKoehne ebmt-2017-wt1-mm
Koehne ebmt-2017-wt1-mm
 
John Ryals- Impacto de las ciencias ómicas en la medicina, nutrición y biotec...
John Ryals- Impacto de las ciencias ómicas en la medicina, nutrición y biotec...John Ryals- Impacto de las ciencias ómicas en la medicina, nutrición y biotec...
John Ryals- Impacto de las ciencias ómicas en la medicina, nutrición y biotec...
 
Bill Faloon Age Reversal Update at DaVinci 50 Masters Conference 2021
Bill Faloon Age Reversal Update at DaVinci 50 Masters Conference 2021Bill Faloon Age Reversal Update at DaVinci 50 Masters Conference 2021
Bill Faloon Age Reversal Update at DaVinci 50 Masters Conference 2021
 
Bill Faloon's Keynote Speech from RAADfest 2021
Bill Faloon's Keynote Speech from RAADfest 2021Bill Faloon's Keynote Speech from RAADfest 2021
Bill Faloon's Keynote Speech from RAADfest 2021
 
Mark A. Atkinson
Mark A. AtkinsonMark A. Atkinson
Mark A. Atkinson
 
Bill Faloon gives update about human age-reversal clinical studies
Bill Faloon gives update about human age-reversal clinical studiesBill Faloon gives update about human age-reversal clinical studies
Bill Faloon gives update about human age-reversal clinical studies
 
Effect of interlukin 36γ and tumor necrosis factorα on patients with polycyst...
Effect of interlukin 36γ and tumor necrosis factorα on patients with polycyst...Effect of interlukin 36γ and tumor necrosis factorα on patients with polycyst...
Effect of interlukin 36γ and tumor necrosis factorα on patients with polycyst...
 
Targeting Biological Aging: A New Paradigm for 21st Century Medicine
Targeting Biological Aging: A New Paradigm for 21st Century MedicineTargeting Biological Aging: A New Paradigm for 21st Century Medicine
Targeting Biological Aging: A New Paradigm for 21st Century Medicine
 
Clinical Trials Update by Bill Faloon at RAADfest 2021
Clinical Trials Update by Bill Faloon at RAADfest 2021Clinical Trials Update by Bill Faloon at RAADfest 2021
Clinical Trials Update by Bill Faloon at RAADfest 2021
 
Unified Theory of Stem Cell Rejuvenation
Unified Theory of Stem Cell RejuvenationUnified Theory of Stem Cell Rejuvenation
Unified Theory of Stem Cell Rejuvenation
 
April 25 webinar Bill Faloon presentation slides
April 25 webinar Bill Faloon presentation slides April 25 webinar Bill Faloon presentation slides
April 25 webinar Bill Faloon presentation slides
 
Pinilla ibarz-j.-et-al.-2006-leukemia
Pinilla ibarz-j.-et-al.-2006-leukemiaPinilla ibarz-j.-et-al.-2006-leukemia
Pinilla ibarz-j.-et-al.-2006-leukemia
 
Bill Faloon at RAADfest 2020
Bill Faloon at RAADfest 2020Bill Faloon at RAADfest 2020
Bill Faloon at RAADfest 2020
 
Evaluation Of Type 1 Gaucher Disease Patients Treated Ith Imiglucerase
Evaluation Of Type 1 Gaucher Disease Patients Treated Ith ImigluceraseEvaluation Of Type 1 Gaucher Disease Patients Treated Ith Imiglucerase
Evaluation Of Type 1 Gaucher Disease Patients Treated Ith Imiglucerase
 
Advances in gaucher disease priya kishnani modified
Advances in gaucher disease  priya kishnani modifiedAdvances in gaucher disease  priya kishnani modified
Advances in gaucher disease priya kishnani modified
 
Maslak p.g.-et-al.-asco-2016-phase-2-acute-myeloid-leukemia-oral-presentation
Maslak p.g.-et-al.-asco-2016-phase-2-acute-myeloid-leukemia-oral-presentationMaslak p.g.-et-al.-asco-2016-phase-2-acute-myeloid-leukemia-oral-presentation
Maslak p.g.-et-al.-asco-2016-phase-2-acute-myeloid-leukemia-oral-presentation
 
Bill Faloon's Keynote Speech from RAADfest 2021
Bill Faloon's Keynote Speech from RAADfest 2021Bill Faloon's Keynote Speech from RAADfest 2021
Bill Faloon's Keynote Speech from RAADfest 2021
 
IgG4 related disease Dr Suresh Gorka
IgG4  related disease Dr Suresh GorkaIgG4  related disease Dr Suresh Gorka
IgG4 related disease Dr Suresh Gorka
 

Semelhante a Neo4j GraphDay Munich - Graphs to fight Diabetes

Neo4j GraphTalk Basel - Using Graph Technology to drive Diabetes Reserach
Neo4j GraphTalk Basel - Using Graph Technology to drive Diabetes ReserachNeo4j GraphTalk Basel - Using Graph Technology to drive Diabetes Reserach
Neo4j GraphTalk Basel - Using Graph Technology to drive Diabetes ReserachNeo4j
 
Concussions and brain health
Concussions and brain healthConcussions and brain health
Concussions and brain healthJohn Bergman
 
Renal disease in diabetes from prediabetes to late vasculopathy complication...
Renal disease in diabetes from prediabetes  to late vasculopathy complication...Renal disease in diabetes from prediabetes  to late vasculopathy complication...
Renal disease in diabetes from prediabetes to late vasculopathy complication...nephro mih
 
20160119 디지털 헬스케어 의사모임 1월 전체 파일 v3
20160119 디지털 헬스케어 의사모임 1월 전체 파일 v320160119 디지털 헬스케어 의사모임 1월 전체 파일 v3
20160119 디지털 헬스케어 의사모임 1월 전체 파일 v3Chiweon Kim
 
UK Biobank: A Prospective Cohort Epidemiology Study
UK Biobank: A Prospective Cohort Epidemiology StudyUK Biobank: A Prospective Cohort Epidemiology Study
UK Biobank: A Prospective Cohort Epidemiology Studyamirhannan
 
Anti-Diabetic Effect of Snake Venoms
Anti-Diabetic Effect of Snake VenomsAnti-Diabetic Effect of Snake Venoms
Anti-Diabetic Effect of Snake VenomsOmar Nawar
 
1. Chronic Disease Avoidance and Personal Longevity - Ultimate Summary.pptx
1. Chronic Disease Avoidance and Personal Longevity - Ultimate Summary.pptx1. Chronic Disease Avoidance and Personal Longevity - Ultimate Summary.pptx
1. Chronic Disease Avoidance and Personal Longevity - Ultimate Summary.pptxIvor Cummins
 
SCOPE School Dublin - Donal O'Shea
SCOPE School Dublin - Donal O'SheaSCOPE School Dublin - Donal O'Shea
SCOPE School Dublin - Donal O'Shea_IASO_
 
Diabetes Diagnosis and Classification
Diabetes Diagnosis and ClassificationDiabetes Diagnosis and Classification
Diabetes Diagnosis and ClassificationDR. VIVEK ARYA
 
lifestyle disorders:diabetes
lifestyle disorders:diabeteslifestyle disorders:diabetes
lifestyle disorders:diabetesLee-Ann Kara
 
2014 12-11 Skipr99 masterclass Arnhem
2014 12-11 Skipr99 masterclass Arnhem2014 12-11 Skipr99 masterclass Arnhem
2014 12-11 Skipr99 masterclass ArnhemAlain van Gool
 
의료 빅데이터와 인공지능의 현재와 미래
의료 빅데이터와 인공지능의 현재와 미래의료 빅데이터와 인공지능의 현재와 미래
의료 빅데이터와 인공지능의 현재와 미래Hyung Jin Choi
 
Advanced glycation end products (AGEs)
Advanced glycation end products (AGEs)Advanced glycation end products (AGEs)
Advanced glycation end products (AGEs)fathi neana
 
PREDICT Study ASN Presentation June 2020
PREDICT Study ASN Presentation June 2020PREDICT Study ASN Presentation June 2020
PREDICT Study ASN Presentation June 2020Sara Gordon
 
Metabolic syndrome
Metabolic syndromeMetabolic syndrome
Metabolic syndromeaswhite
 
01&02 rencontres biomédicale Christian Boitard
01&02 rencontres biomédicale Christian Boitard01&02 rencontres biomédicale Christian Boitard
01&02 rencontres biomédicale Christian BoitardAssociation LIR
 
Cancer as a metabolic disease 2
Cancer as a metabolic disease 2Cancer as a metabolic disease 2
Cancer as a metabolic disease 2fathi neana
 

Semelhante a Neo4j GraphDay Munich - Graphs to fight Diabetes (20)

Neo4j GraphTalk Basel - Using Graph Technology to drive Diabetes Reserach
Neo4j GraphTalk Basel - Using Graph Technology to drive Diabetes ReserachNeo4j GraphTalk Basel - Using Graph Technology to drive Diabetes Reserach
Neo4j GraphTalk Basel - Using Graph Technology to drive Diabetes Reserach
 
Concussions and brain health
Concussions and brain healthConcussions and brain health
Concussions and brain health
 
Renal disease in diabetes from prediabetes to late vasculopathy complication...
Renal disease in diabetes from prediabetes  to late vasculopathy complication...Renal disease in diabetes from prediabetes  to late vasculopathy complication...
Renal disease in diabetes from prediabetes to late vasculopathy complication...
 
20160119 디지털 헬스케어 의사모임 1월 전체 파일 v3
20160119 디지털 헬스케어 의사모임 1월 전체 파일 v320160119 디지털 헬스케어 의사모임 1월 전체 파일 v3
20160119 디지털 헬스케어 의사모임 1월 전체 파일 v3
 
Diabetes
DiabetesDiabetes
Diabetes
 
UK Biobank: A Prospective Cohort Epidemiology Study
UK Biobank: A Prospective Cohort Epidemiology StudyUK Biobank: A Prospective Cohort Epidemiology Study
UK Biobank: A Prospective Cohort Epidemiology Study
 
Anti-Diabetic Effect of Snake Venoms
Anti-Diabetic Effect of Snake VenomsAnti-Diabetic Effect of Snake Venoms
Anti-Diabetic Effect of Snake Venoms
 
1. Chronic Disease Avoidance and Personal Longevity - Ultimate Summary.pptx
1. Chronic Disease Avoidance and Personal Longevity - Ultimate Summary.pptx1. Chronic Disease Avoidance and Personal Longevity - Ultimate Summary.pptx
1. Chronic Disease Avoidance and Personal Longevity - Ultimate Summary.pptx
 
SCOPE School Dublin - Donal O'Shea
SCOPE School Dublin - Donal O'SheaSCOPE School Dublin - Donal O'Shea
SCOPE School Dublin - Donal O'Shea
 
Diabetes Diagnosis and Classification
Diabetes Diagnosis and ClassificationDiabetes Diagnosis and Classification
Diabetes Diagnosis and Classification
 
lifestyle disorders:diabetes
lifestyle disorders:diabeteslifestyle disorders:diabetes
lifestyle disorders:diabetes
 
2014 12-11 Skipr99 masterclass Arnhem
2014 12-11 Skipr99 masterclass Arnhem2014 12-11 Skipr99 masterclass Arnhem
2014 12-11 Skipr99 masterclass Arnhem
 
의료 빅데이터와 인공지능의 현재와 미래
의료 빅데이터와 인공지능의 현재와 미래의료 빅데이터와 인공지능의 현재와 미래
의료 빅데이터와 인공지능의 현재와 미래
 
Advanced glycation end products (AGEs)
Advanced glycation end products (AGEs)Advanced glycation end products (AGEs)
Advanced glycation end products (AGEs)
 
Diabesity with Sharon Weinstein
Diabesity with Sharon WeinsteinDiabesity with Sharon Weinstein
Diabesity with Sharon Weinstein
 
PREDICT Study ASN Presentation June 2020
PREDICT Study ASN Presentation June 2020PREDICT Study ASN Presentation June 2020
PREDICT Study ASN Presentation June 2020
 
Metabolic syndrome
Metabolic syndromeMetabolic syndrome
Metabolic syndrome
 
01&02 rencontres biomédicale Christian Boitard
01&02 rencontres biomédicale Christian Boitard01&02 rencontres biomédicale Christian Boitard
01&02 rencontres biomédicale Christian Boitard
 
Endocrine Disorder.pptx
Endocrine Disorder.pptxEndocrine Disorder.pptx
Endocrine Disorder.pptx
 
Cancer as a metabolic disease 2
Cancer as a metabolic disease 2Cancer as a metabolic disease 2
Cancer as a metabolic disease 2
 

Mais de Neo4j

Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...
Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...
Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...Neo4j
 
Neo4j - How KGs are shaping the future of Generative AI at AWS Summit London ...
Neo4j - How KGs are shaping the future of Generative AI at AWS Summit London ...Neo4j - How KGs are shaping the future of Generative AI at AWS Summit London ...
Neo4j - How KGs are shaping the future of Generative AI at AWS Summit London ...Neo4j
 
QIAGEN: Biomedical Knowledge Graphs for Data Scientists and Bioinformaticians
QIAGEN: Biomedical Knowledge Graphs for Data Scientists and BioinformaticiansQIAGEN: Biomedical Knowledge Graphs for Data Scientists and Bioinformaticians
QIAGEN: Biomedical Knowledge Graphs for Data Scientists and BioinformaticiansNeo4j
 
EY_Graph Database Powered Sustainability
EY_Graph Database Powered SustainabilityEY_Graph Database Powered Sustainability
EY_Graph Database Powered SustainabilityNeo4j
 
SIEMENS: RAPUNZEL – A Tale About Knowledge Graph
SIEMENS: RAPUNZEL – A Tale About Knowledge GraphSIEMENS: RAPUNZEL – A Tale About Knowledge Graph
SIEMENS: RAPUNZEL – A Tale About Knowledge GraphNeo4j
 
Build your next Gen AI Breakthrough - April 2024
Build your next Gen AI Breakthrough - April 2024Build your next Gen AI Breakthrough - April 2024
Build your next Gen AI Breakthrough - April 2024Neo4j
 
Connecting the Dots for Information Discovery.pdf
Connecting the Dots for Information Discovery.pdfConnecting the Dots for Information Discovery.pdf
Connecting the Dots for Information Discovery.pdfNeo4j
 
ISDEFE - GraphSummit Madrid - ARETA: Aviation Real-Time Emissions Token Accre...
ISDEFE - GraphSummit Madrid - ARETA: Aviation Real-Time Emissions Token Accre...ISDEFE - GraphSummit Madrid - ARETA: Aviation Real-Time Emissions Token Accre...
ISDEFE - GraphSummit Madrid - ARETA: Aviation Real-Time Emissions Token Accre...Neo4j
 
BBVA - GraphSummit Madrid - Caso de éxito en BBVA: Optimizando con grafos
BBVA - GraphSummit Madrid - Caso de éxito en BBVA: Optimizando con grafosBBVA - GraphSummit Madrid - Caso de éxito en BBVA: Optimizando con grafos
BBVA - GraphSummit Madrid - Caso de éxito en BBVA: Optimizando con grafosNeo4j
 
Graph Everywhere - Josep Taruella - Por qué Graph Data Science en tus modelos...
Graph Everywhere - Josep Taruella - Por qué Graph Data Science en tus modelos...Graph Everywhere - Josep Taruella - Por qué Graph Data Science en tus modelos...
Graph Everywhere - Josep Taruella - Por qué Graph Data Science en tus modelos...Neo4j
 
GraphSummit Madrid - Product Vision and Roadmap - Luis Salvador Neo4j
GraphSummit Madrid - Product Vision and Roadmap - Luis Salvador Neo4jGraphSummit Madrid - Product Vision and Roadmap - Luis Salvador Neo4j
GraphSummit Madrid - Product Vision and Roadmap - Luis Salvador Neo4jNeo4j
 
Neo4j_Exploring the Impact of Graph Technology on Financial Services.pdf
Neo4j_Exploring the Impact of Graph Technology on Financial Services.pdfNeo4j_Exploring the Impact of Graph Technology on Financial Services.pdf
Neo4j_Exploring the Impact of Graph Technology on Financial Services.pdfNeo4j
 
Rabobank_Exploring the Impact of Graph Technology on Financial Services.pdf
Rabobank_Exploring the Impact of Graph Technology on Financial Services.pdfRabobank_Exploring the Impact of Graph Technology on Financial Services.pdf
Rabobank_Exploring the Impact of Graph Technology on Financial Services.pdfNeo4j
 
Webinar - IA generativa e grafi Neo4j: RAG time!
Webinar - IA generativa e grafi Neo4j: RAG time!Webinar - IA generativa e grafi Neo4j: RAG time!
Webinar - IA generativa e grafi Neo4j: RAG time!Neo4j
 
IA Generativa y Grafos de Neo4j: RAG time
IA Generativa y Grafos de Neo4j: RAG timeIA Generativa y Grafos de Neo4j: RAG time
IA Generativa y Grafos de Neo4j: RAG timeNeo4j
 
Neo4j: Data Engineering for RAG (retrieval augmented generation)
Neo4j: Data Engineering for RAG (retrieval augmented generation)Neo4j: Data Engineering for RAG (retrieval augmented generation)
Neo4j: Data Engineering for RAG (retrieval augmented generation)Neo4j
 
Neo4j Graph Summit 2024 Workshop - EMEA - Breda_and_Munchen.pdf
Neo4j Graph Summit 2024 Workshop - EMEA - Breda_and_Munchen.pdfNeo4j Graph Summit 2024 Workshop - EMEA - Breda_and_Munchen.pdf
Neo4j Graph Summit 2024 Workshop - EMEA - Breda_and_Munchen.pdfNeo4j
 
Enabling GenAI Breakthroughs with Knowledge Graphs
Enabling GenAI Breakthroughs with Knowledge GraphsEnabling GenAI Breakthroughs with Knowledge Graphs
Enabling GenAI Breakthroughs with Knowledge GraphsNeo4j
 
Neo4j_Anurag Tandon_Product Vision and Roadmap.Benelux.pptx.pdf
Neo4j_Anurag Tandon_Product Vision and Roadmap.Benelux.pptx.pdfNeo4j_Anurag Tandon_Product Vision and Roadmap.Benelux.pptx.pdf
Neo4j_Anurag Tandon_Product Vision and Roadmap.Benelux.pptx.pdfNeo4j
 
Neo4j Jesus Barrasa The Art of the Possible with Graph
Neo4j Jesus Barrasa The Art of the Possible with GraphNeo4j Jesus Barrasa The Art of the Possible with Graph
Neo4j Jesus Barrasa The Art of the Possible with GraphNeo4j
 

Mais de Neo4j (20)

Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...
Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...
Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...
 
Neo4j - How KGs are shaping the future of Generative AI at AWS Summit London ...
Neo4j - How KGs are shaping the future of Generative AI at AWS Summit London ...Neo4j - How KGs are shaping the future of Generative AI at AWS Summit London ...
Neo4j - How KGs are shaping the future of Generative AI at AWS Summit London ...
 
QIAGEN: Biomedical Knowledge Graphs for Data Scientists and Bioinformaticians
QIAGEN: Biomedical Knowledge Graphs for Data Scientists and BioinformaticiansQIAGEN: Biomedical Knowledge Graphs for Data Scientists and Bioinformaticians
QIAGEN: Biomedical Knowledge Graphs for Data Scientists and Bioinformaticians
 
EY_Graph Database Powered Sustainability
EY_Graph Database Powered SustainabilityEY_Graph Database Powered Sustainability
EY_Graph Database Powered Sustainability
 
SIEMENS: RAPUNZEL – A Tale About Knowledge Graph
SIEMENS: RAPUNZEL – A Tale About Knowledge GraphSIEMENS: RAPUNZEL – A Tale About Knowledge Graph
SIEMENS: RAPUNZEL – A Tale About Knowledge Graph
 
Build your next Gen AI Breakthrough - April 2024
Build your next Gen AI Breakthrough - April 2024Build your next Gen AI Breakthrough - April 2024
Build your next Gen AI Breakthrough - April 2024
 
Connecting the Dots for Information Discovery.pdf
Connecting the Dots for Information Discovery.pdfConnecting the Dots for Information Discovery.pdf
Connecting the Dots for Information Discovery.pdf
 
ISDEFE - GraphSummit Madrid - ARETA: Aviation Real-Time Emissions Token Accre...
ISDEFE - GraphSummit Madrid - ARETA: Aviation Real-Time Emissions Token Accre...ISDEFE - GraphSummit Madrid - ARETA: Aviation Real-Time Emissions Token Accre...
ISDEFE - GraphSummit Madrid - ARETA: Aviation Real-Time Emissions Token Accre...
 
BBVA - GraphSummit Madrid - Caso de éxito en BBVA: Optimizando con grafos
BBVA - GraphSummit Madrid - Caso de éxito en BBVA: Optimizando con grafosBBVA - GraphSummit Madrid - Caso de éxito en BBVA: Optimizando con grafos
BBVA - GraphSummit Madrid - Caso de éxito en BBVA: Optimizando con grafos
 
Graph Everywhere - Josep Taruella - Por qué Graph Data Science en tus modelos...
Graph Everywhere - Josep Taruella - Por qué Graph Data Science en tus modelos...Graph Everywhere - Josep Taruella - Por qué Graph Data Science en tus modelos...
Graph Everywhere - Josep Taruella - Por qué Graph Data Science en tus modelos...
 
GraphSummit Madrid - Product Vision and Roadmap - Luis Salvador Neo4j
GraphSummit Madrid - Product Vision and Roadmap - Luis Salvador Neo4jGraphSummit Madrid - Product Vision and Roadmap - Luis Salvador Neo4j
GraphSummit Madrid - Product Vision and Roadmap - Luis Salvador Neo4j
 
Neo4j_Exploring the Impact of Graph Technology on Financial Services.pdf
Neo4j_Exploring the Impact of Graph Technology on Financial Services.pdfNeo4j_Exploring the Impact of Graph Technology on Financial Services.pdf
Neo4j_Exploring the Impact of Graph Technology on Financial Services.pdf
 
Rabobank_Exploring the Impact of Graph Technology on Financial Services.pdf
Rabobank_Exploring the Impact of Graph Technology on Financial Services.pdfRabobank_Exploring the Impact of Graph Technology on Financial Services.pdf
Rabobank_Exploring the Impact of Graph Technology on Financial Services.pdf
 
Webinar - IA generativa e grafi Neo4j: RAG time!
Webinar - IA generativa e grafi Neo4j: RAG time!Webinar - IA generativa e grafi Neo4j: RAG time!
Webinar - IA generativa e grafi Neo4j: RAG time!
 
IA Generativa y Grafos de Neo4j: RAG time
IA Generativa y Grafos de Neo4j: RAG timeIA Generativa y Grafos de Neo4j: RAG time
IA Generativa y Grafos de Neo4j: RAG time
 
Neo4j: Data Engineering for RAG (retrieval augmented generation)
Neo4j: Data Engineering for RAG (retrieval augmented generation)Neo4j: Data Engineering for RAG (retrieval augmented generation)
Neo4j: Data Engineering for RAG (retrieval augmented generation)
 
Neo4j Graph Summit 2024 Workshop - EMEA - Breda_and_Munchen.pdf
Neo4j Graph Summit 2024 Workshop - EMEA - Breda_and_Munchen.pdfNeo4j Graph Summit 2024 Workshop - EMEA - Breda_and_Munchen.pdf
Neo4j Graph Summit 2024 Workshop - EMEA - Breda_and_Munchen.pdf
 
Enabling GenAI Breakthroughs with Knowledge Graphs
Enabling GenAI Breakthroughs with Knowledge GraphsEnabling GenAI Breakthroughs with Knowledge Graphs
Enabling GenAI Breakthroughs with Knowledge Graphs
 
Neo4j_Anurag Tandon_Product Vision and Roadmap.Benelux.pptx.pdf
Neo4j_Anurag Tandon_Product Vision and Roadmap.Benelux.pptx.pdfNeo4j_Anurag Tandon_Product Vision and Roadmap.Benelux.pptx.pdf
Neo4j_Anurag Tandon_Product Vision and Roadmap.Benelux.pptx.pdf
 
Neo4j Jesus Barrasa The Art of the Possible with Graph
Neo4j Jesus Barrasa The Art of the Possible with GraphNeo4j Jesus Barrasa The Art of the Possible with Graph
Neo4j Jesus Barrasa The Art of the Possible with Graph
 

Último

DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDropbox
 
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyKhushali Kathiriya
 
Exploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusExploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusZilliz
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherRemote DBA Services
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processorsdebabhi2
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc
 
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...Zilliz
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...apidays
 
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUKSpring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUKJago de Vreede
 
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...apidays
 
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProduct Anonymous
 
Cyberprint. Dark Pink Apt Group [EN].pdf
Cyberprint. Dark Pink Apt Group [EN].pdfCyberprint. Dark Pink Apt Group [EN].pdf
Cyberprint. Dark Pink Apt Group [EN].pdfOverkill Security
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...apidays
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MIND CTI
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWERMadyBayot
 
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...apidays
 
AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024The Digital Insurer
 
Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024The Digital Insurer
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerThousandEyes
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfsudhanshuwaghmare1
 

Último (20)

DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : Uncertainty
 
Exploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusExploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with Milvus
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a Fresher
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processors
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
 
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUKSpring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
 
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
 
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
 
Cyberprint. Dark Pink Apt Group [EN].pdf
Cyberprint. Dark Pink Apt Group [EN].pdfCyberprint. Dark Pink Apt Group [EN].pdf
Cyberprint. Dark Pink Apt Group [EN].pdf
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
 
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
 
AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024
 
Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected Worker
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdf
 

Neo4j GraphDay Munich - Graphs to fight Diabetes

  • 1. Graphs to fight diabetes Dr. Alexander Jarasch Head of Data and Knowledge Management The German Center for Diabetes Research (DZD)
  • 2. Evolutionary advantage becomes disadvantage energy storage essential for survival upon lack of food energy storage essential for survival upon food abundance
  • 3. What is diabetes mellitus? • metabolic disease • insulin production is reduced in pancreas or body poorly responds on insulin (insulin=hormone, the body needs to get glucose out of the blood stream into the cells) • consequences: • less absorbtion of sugar • sugar will not be stored in liver and muscle cells • persistently high levels of sugar in blood (hyperglycemia) • tremendous complications • currently, not curable (only treatable) diabetes T1D diabetes Gestational diabetes special types T2D diabetes
  • 4. Diabetes TYPE 1 (T1D) • appr. 5-10 % of diabetes patients have T1D • often starts in childhood • autoimmune reaction • independent from life style • patients need external insulin source throughout their life • appr. 20 genes involved • currently, T1D is not curable
  • 5. Diabetes TYPE 2 (T2D) • appr. 90-95 % of diabetes patients have T2D (mostly after age 40) • insulin resistance, pancreas is not able to produce enough insulin • symptoms develop slowly • >150 genes are identified that increase risk • “the cocktail of evil“: predisposition + overweight + physical inactivity
  • 6. Some numbers (worldwide) 1 in 11 adults has diabetes (425 million) Since 1980 quadrupled 12% of global health expenditure is spent on diabetes ($727 billion) Over 1 million children and adolescents have type 1 diabetes Two-thirds of people with diabetes are of working age (327 million) 2017 Three quarters of people with diabetes live in low and middle income countries 2017 1 in 2 adults with diabetes is undiagnosed (212 million) International Diabetes Federation (IDF)
  • 7. Some numbers (USA and Germany) 30 million have diabetes (9.4 % of adults )1 +1‘500‘000 p.a. 84 mio. prediabetes2 16 billion € costs p.a.1 7 million have diabetes (7.4 % of adults)1 +500‘000 p.a. ~ 7 mio. prediabetes and undiagnozed $327 billion USD costs p.a.1 ($237 bn. medical costs, $90 bn. reduced productivity)2 1 www.statistica.com 2 American Diabetes Association
  • 8. Overweight/obesity in the US (1985- 2009) obese adults in the US (BMI* >= 30) *BMI=30: 5”11 = 220,46 lbs (180cm = 100 kg)
  • 9. Complications develop after many years kidney Diabetic nephropathy 40 % of kidney failure/dialysis feet 70 % of all foot amputations eyes Diabetic retinopathy 30 % of loss of sight brain 2-4 fold increased risk for stroke acute cardiac death Main reason of death of diabetic patients (33 % of all heart attacks) nerves Diabetic Neuropathy Amputations of extremeties
  • 10. Complex emergence / complex disease live style gene epigenetics metabolism cellular processes environment
  • 12. Epigenetics – beyond generation weight[g] age [weeks] daughters of obese mice having diabtes daughters of healthy mice Huypens and Beckers, Nat Genet. 2016
  • 13. The German Center for Diabetes Research funded by the Federal Ministry for Education and Research and the states 5 Partners, 5 associated partners – 400 researchers (basic research and university hospitals) DZD bundles competencies so that those affected benefit more quickly from research results. academic, non-profit
  • 14. The German Center for Diabetes Research hospitals prevention nutrition / diet beta cells genetics therapy clinial studies cohorts basic researchhealthcare diabetes treatment diabetes prevention prevention of complications
  • 15. Goal: better diabetes prevention and therapy personalized prevention and therapy identify and cluster diabetes subtypes individualized treatment of subtypes
  • 16. How do we fight diabetes with graphs?
  • 17. The challenge Easy question -> Complex query Find information within our organisation
  • 18. Originally different research areas Hospitals Basic Research Data Analysis
  • 19. We all “serve“ the same “customer“ Hospitals Basic Research Data Analysis
  • 20. But we all see the “customer“ a little differently “Patient“ “Gene“ “Study“ “Metabolite“ “drug“ “statistics“ 64kg, 178cm, male C6H12O6 Metformin T2D AAGCTTCACATGG cell insulin resistance inactive mice prediabetic pig microscope image complications
  • 21. Look at our “customer“ in a new way “Patient“ “Gene“ “Study“ “Metabolite“ “drug“ “statistics“ 64kg, 178cm, male C6H12O6 Metformin T2D AAGCTTCACATGG cell insulin resistance inactive mice prediabetic pig microscope image complications
  • 22. Look at our “customer“ from many perspectives simultaneously – connect data Hospitals Basic Research Data Analysis data
  • 23. Connect data – one option Hospitals Basic Research Data Analysis “Patient“ 64kg, 178cm, male “drug“ Metformin “Study“ T2D insulin resistance “Gene“ AAGCTTCACATGG “Metabolite“ C6H12O6 cell inactive mice prediabetic pig “statistics“ microscope image complications
  • 24. Connect data – better option “Patient“ 64kg, 178cm, male “drug“ Metformin “Study“ T2D “statistics“ “Gene“ AAGCTTCACATGG “Metabolite“ C6H12O6 insulin resistance cell inactive mice prediabetic pig microscope image complications
  • 25. DZDConnect – a Neo4j graph database Graph that can help answering bio-medical questions across locations across disciplines across species extendable scalable visualizable
  • 27. (First) connect data a meta level RAW DATA RAW DATA RAW DATA RAW DATA RAW DATA
  • 29. Classify types of data clin. study clin. study clin. study statis tics statis tics RNA DNA RNA DNA images chem istry patient patient patient bio sample bio sample bio sample wet lab chem istry drug
  • 30. Connect types of data statis tics statis tics RNA DNA images chem istry patient wet lab chem istry drug patient patient bio sample bio sample bio sample clin. study clin. study clin. study RNA DNA
  • 32. Why graph? • in „biology“ everything is connected anyway • data is connected • human readable – easy-to-understand for non-computer scientists • easy to query: queries are similar to human-like questions • scalable • easy-adoptable and extendable • visualization
  • 33. Meta data name: IL-6 unit: mg/ml sample: blood organism: pig amount: 50ml aliquots: 362 location: Freezer68 name: pancreas dissection format: TIFF dimension: 3840x2160 amount: 125 staining: no staining microscope: Zeiss Light sheet Z1 location: Dresden title: „about diabetes and Alzheimer‘s“ PMID: 1255864 doi: http://doi.102r3d year: 2016 journal: Diabetes
  • 35. lipid metabolism Diabetes is a metabolic disease
  • 36.
  • 37. Extending our graph RNA-seq proteomicsAssociations ~800 mio. nodes ~800 mio. relationships Dr. Martin Preusse Dr. Nikola Müller
  • 38. Extending our graph Dr. Jan Krumsiek, Assistant Professor, Weill Cornell Medicine, NYC metabolic pathway data from 15-20 very rich data sources ~900’000 nodes ~1.7 mio. relationships phenotype associations studies
  • 41. How many biosamples were aquired in visit 17 of ‘PLIS‘ and which parameters were measured?Goals: 1. Connect data from our clinical studies and biobanks 2. Researches can easily browse through measured parameters and available biosamples 3. Meta data of parameters helps to assess which samples are comparable
  • 42. name: HMGU name: AJ position: data mgmt name: PLIS multi-center: true recruiting: closed analysis: on-going no. of patients: 1105 visit: 17 name: blood type: OGTT number of samples: 3436 organism: Human name: laboratory
  • 43. Study
  • 46. Can human T2D genes be studied in the pre-diabetic pig model? Goals: 1. Connect data from different species (i.e. mice, pig, human) 2. Connect multiomics data 3. Researches can easily find information between human and comparable data from animal models
  • 48. Human GWAS cataloge (Diabetes) 103 genes 97 genes 96 genes 16 enzymes 63 compounds 31 compounds 7 compounds 16 metabolites Targeted metabolomics analysis in prediabetic pig ENSEMBL Gennamen (human) KEGG Gen IDs KEGG Enzyme KEGG compounds Biocrates IDs 7/16 metabolites Xxaa C11:0 Xxaa C11:1 Xxaa C11:2 Xxaa C11:3 Xxaa C11:4 Xxaa C11:5 Xxaa C11:6 genomics transcriptomics proteomics metabolomics pathway analysis
  • 50. Automatically learn from large literature texts
  • 51. Natural language processing (NLP) example Identification of genetic elements in metabolism by high-throughput mouse phenotyping. Metabolic diseases are a worldwide problem but the underlying genetic factors and their relevance to metabolic disease remain incompletely understood. Genome-wide research is needed to characterize so-far unannotated mammalian metabolic genes. Here, we generate and analyze metabolic phenotypic data of 2016 knockout mouse strains under the aegis of the International Mouse Phenotyping Consortium (IMPC) and find 974 gene knockouts with strong metabolic phenotypes. 429 of those had no previous link to metabolism and 51 genes remain functionally completely unannotated. We compared human orthologues of these uncharacterized genes in five GWAS consortia and indeed 23 candidate genes, like ABC1, XYZ2, are associated with metabolic disease. We further identify common regulatory elements in promoters of candidate genes. As each regulatory element is composed of several transcription factor binding sites, our data reveal an extensive metabolic phenotype-associated network of co-regulated genes. Our systematic mouse phenotype analysis thus paves the way for full functional annotation of the genome. Metabolic disorders, including obesity and type 2 diabetes mellitus, are major challenges for public health. Rozman and Hrabe de Angelis, Nat Commun. 2018 NLP method by GraphAware
  • 53. Machine learning for personalized prevention and therapy identify and cluster diabetes subtypes individualized treatment of subtypes Expert Knowledge validation of personalized treatment Graph Technology
  • 54. DDPC – Digital Diabetes Prevention Center • pattern recognition in huge amounts of data • (un)supervised ML methods to identify subtypes of diabetes • developing/validating individulized prevention/therapy transparency to people benefit for people benefit for society
  • 55. Next level in diabetes prevention and treatment Hospitals Basic Research Data Analysis
  • 56. Acknowledgements The scientists of the DZD at: Funding by:

Notas do Editor

  1. lebenstil der eltern vor zeugung hat einfluss bereits für risk obisisty für die knder durch epigenetische enflüsse VOR der schwangerschaft
  2. cover all aspects of diabetes research from molecular studies in cell models. and animal models to clinicial investigations in patients and health care research